Overview
Investment Type
Venture Capital
Funds raised 1
| Date | Fund size | Announcement |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 12
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 6, 2012 | iPads in the OR: New mobile platform to monitor blood loss during surgery | Other methods for measuring blood loss — like a catheter that’s inserted into the heart to transmit information to a monitor — are invasive and still inaccurate. There’s been some research and innovation in this field in recent years, but m... |
| Jun 22, 2010 | CVRx touts clinical trial results of blood pressure neurostim device | By Thomas Lee CVRx Inc. of Plymouth, Minn., said Monday that hypertension patients using its Rheos stimulation device reported a sharp drop in blood pressure after four years. In a study presented at the European Society of Hypertension mee... |
| Jun 21, 2010 | CVRx reports positive four-year results for its anti-blood pressure device | Promoted This Patient Experience Checklist Is Your Key To Success in 2021 As healthcare systems strive to recover from losses due to the pandemic, patient acquisition and retention have never been more urgent, and patient experience has nev... |
| Oct 13, 2009 | Cincinnati’s Akebia Therapeutics races (as safely as possible) toward new anemia treatment | Akebia is in a race to develop its drug against other treatments supported by the likes of GlaxoSmithKline and Takeda Pharmaceuticals that are further along in their trials. The company thinks it can make up ground. Plus, even if it isn’t f... |
| Jul 29, 2009 | Cardiovascular biopharma Akebia takes additional funding to develop 2 drugs | Promoted Covid-19’s terrible toll on diabetes patients. What can be done? The public health crisis has undermined the economy and made people with chronic conditions more vulnerable and stressed. Learn more with a new report from Omada Heal... |
| Sep 2, 2008 | Spinal device developer Baxano raises $20M | Baxano, a startup in stealth mode that’s developing a spinal medical device, has raised $20 million in a second round of funding, according to VentureWire. The round was led by new backer Kearny Venture Partners, with participation from exi... |
| Oct 16, 2006 | Kearny Venture Partners raises $85M of planned $180M fund for healthcare | Kearny Venture Partners, a healthcare focused venture capital firm in San Francisco, has raised an initial $85 million for its latest fund. The news was first reported by PE Week last week, and followed today by VentureWire (sub required) w... |
| CVRx reports positive four-year results for its anti-blood pressure device | CVRx Inc. in Plymouth, Minn. said Monday that hypertension patients using its Rheos stimulation device reported a sharp drop in blood pressure after four years. In a study presented to the European Society of Hypertension meeting, the compa... | |
| Cardiovascular biopharma Akebia takes additional funding to develop 2 drugs | CINCINNATI, Ohio — Cardiovascular drugmaker Akebia Therapeutics will add $10 million more than expected to its Series A fund-raise, bringing the total to $25 million, the company stated (pdf). The company stated it raised additional money t... |
Show more
Reviews 0
FAQ about Kearny Venture Partners
What funds has Kearny Venture Partners raised?
Kearny Venture Partners has announced 1 fund on Parsers VC.
What has the press written about Kearny Venture Partners?
Parsers VC has collected 12 articles mentioning Kearny Venture Partners, among them “iPads in the OR: New mobile platform to monitor blood loss during surgery” (Jun 6, 2012) and “CVRx touts clinical trial results of blood pressure neurostim device” (Jun 22, 2010).
Is Kearny Venture Partners still active?
Yes, Kearny Venture Partners is active; its latest activity on Parsers VC dates from Oct 5, 2013.